Martin, A. G., Braicu, E. I., Kumar, P. P., Hasegawa, K., Covens, A., Damian, F., Brasiuniene, B., Tan, D. S. P., Valabrega, G., Stillie, A., Talekar, M., Zhou, X., Cloven, N. (2026). RAINFOL-03 (ENGOT-EN-31/GOG-3128): A global, phase 3, open-label, randomized study of rinatabart sesutecan (Rina-S) vs investigator’s choice of chemotherapy in patients with endometrial cancer after platinum-based chemotherapy and programmed death-ligand 1 inhibition.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5646